Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Goldfinger · SciRah

Researcher profile · Semantic Scholar

M. Goldfinger

Share profile

M. Goldfinger — researcher profile on SciRah

h-index: 16
Works: 163
Citations: 1,605

Most-cited papers

Real-world experience of combined treatment with azacitidine and romidepsin in patients with peripheral T-cell lymphoma
M. Kalac, Salvia Jain, C. Tam, Zheng-Rui Xiao +6 more
2023Blood Advances21 citations Open access
Semantic Scholar
A weekly low-dose regimen of decitabine and venetoclax is efficacious and less myelotoxic in a racially diverse cohort
M. Goldfinger, Ioannis Mantzaris, Aditi Shastri, Y. Saunthararajah +23 more
2024Blood20 citations Open access
Semantic Scholar
Pharmacological restriction of genomic binding sites redirects PU.1 pioneer transcription factor activity
Samuel J. Taylor, Jacob Stauber, Oliver Bohorquez, Goichi Tatsumi +14 more
2024Nature Genetics18 citations Open access
Semantic Scholar
A Metabolically Optimized, Noncytotoxic Low-Dose Weekly Decitabine/Venetoclax in MDS and AML.
D. Levitz, Y. Saunthararajah, Kateryna Fedorov, Lauren C. Shapiro +13 more
2023Clinical Cancer Research18 citations Open access
Semantic Scholar
Venetoclax plus daunorubicin and cytarabine for newly diagnosed acute myeloid leukemia: results of a phase 1b study
Ioannis Mantzaris, M. Goldfinger, Matan Uriel, Aditi Shastri +19 more
2025Blood17 citations Open access
Semantic Scholar
Phenomenon of tumor flare with talquetamab in a patient with extramedullary myeloma
Mark Forsberg, Santiago Beltran, M. Goldfinger, Murali Janakiram +4 more
2024Haematologica17 citations Open access
Semantic Scholar
Immunotherapy-resistant acute lymphoblastic leukemia cells exhibit reduced CD19 and CD22 expression and BTK pathway dependency
Sarah Aminov, Orsi Giricz, D. Melnekoff, R. Sica +23 more
2024Journal of Clinical Investigation14 citations Open access
Semantic Scholar
A STAT3 Degrader Demonstrates Pre-Clinical Efficacy in Venetoclax Resistant Acute Myeloid Leukemia
S. Chakraborty, Claudia Morganti, Joyoti Dey, Hui Zhang +20 more
2023Blood12 citations Open access
Semantic Scholar
Outcome of Stem Cell Transplantation in HTLV-1-Associated North American Adult T-Cell Leukemia/Lymphoma
A. Bazarbachi, D. Reef, Hiba G. Narvel, Riya Patel +37 more
2023Clinical Hematology International10 citations Open access
Semantic Scholar
Improving unrelated donor equity: assessing mismatched donor opportunities with real world data in a minority-predominant cohort.
M. B. Hammami, J. Verceles, M. Goldfinger, Nishi Shah +10 more
2024Transplantation and Cellular Therapy9 citations Open access
Semantic Scholar
A STAT3 degrader demonstrates efficacy in venetoclax resistant acute myeloid leukemia
S. Chakraborty, C. Morganti, K. Zaldaña, Bianca Rivera Pena +29 more
2026Leukemia6 citations Open access
Semantic Scholar
Combining drugs that bypass p53 to treat TP53-mutated leukemias
Sudipta Biswas, Z. Zahran, Xiaorong Gu, Lisa Cardone +9 more
2025Blood Advances5 citations Open access
Semantic Scholar
Socio-demographic determinants of myelofibrosis outcomes in an underserved center and the SEER national database
John Yan, M. B. Hammami, John X. Wei, Nishi Shah +14 more
2024Annals of Hematology5 citations Open access
Semantic Scholar
Autologous stem cell transplantation in an older adult population
Kateryna Fedorov, Tanim Jain, K. Pradhan, Jennat Mustafa +22 more
2022Haematologica5 citations Open access
Semantic Scholar
Impact of race and ethnicity on early mortality in multiple myeloma: a SEER analysis
John X. Wei, Aditi Shastri, R. Sica, Ioannis Mantzaris +8 more
2023Haematologica4 citations Open access
Semantic Scholar
Treatment of TP53-mutated myelodysplastic syndrome and acute myeloid leukemia with low-intensity metronomic decitabine and venetoclax
M. Goldfinger, Ioannis Mantzaris, Aditi Shastri, Bradley Rockwell +23 more
2026Haematologica3 citations Open access
Semantic Scholar
Assessing the performance of the Iceland screens, treats, or prevents multiple myeloma (iStopMM) model in a multicultural Bronx cohort: implications for monoclonal gammopathy of undetermined significance risk stratification
Rajvi Gor, Jeevan Shivakumar, Pallavi Surana, John X. Wei +16 more
2025Blood Cancer Journal2 citations Open access
Semantic Scholar
Venetoclax Combined with “7+3” Induction Chemotherapy Induces High MRD-Negative Response Rates in Newly Diagnosed AML Patients Fit for Intensive Chemotherapy across Ages
Ioannis Mantzaris, Matan Uriel, M. Goldfinger, Aditi Shastri +18 more
2024Blood2 citations
Semantic Scholar
A Phase 1 Study Investigating the Safety and Efficacy of Danvatirsen As Monotherapy Followed By Combination with Venetoclax in Patients with Relapsed/Refractory MDS and AML
Aditi Shastri, M. Goldfinger, Ioannis Mantzaris, G. Garcia-Manero +30 more
2024Blood2 citations
Semantic Scholar
Acute myeloid leukemias with JAK2/STAT mutations are associated with PD-L1 upregulation
Jiani N. Chai, J. Choudhuri, Qing Wang, Yanan Fang +14 more
2023Leukemia and Lymphoma2 citations
Semantic Scholar
High Dose Cyclophosphamide for the Treatment of Severe Immune Checkpoint Inhibitor Related Adverse Events
T. Davis, Kateryna Fedorov, Peter Gregos, Lauren C. Shapiro +12 more
2023Journal of Oncology Research and Therapeutics2 citations Open access
Semantic Scholar
Chimeric Antigen Receptor T-Cell Therapy for Patients With Multiple Myeloma-A Call for Equal Opportunity.
M. Goldfinger, Nishi Shah, D. Cooper
2023JAMA Oncology2 citations
Semantic Scholar
Venetoclax Combined with “7+3” Induction Chemotherapy Induces High Rates of MRD-Negative Remission in Newly Diagnosed AML Patients Fit for Intensive Chemotherapy Irrespective of Age
Ioannis Mantzaris, M. Goldfinger, Nishi Shah, Anne Munoz +14 more
2023Blood2 citations Open access
Semantic Scholar
Pyrimethamine, a STAT3 Inhibitor, Synergizes with Venetoclax and Shows Efficacy in Hypomethylating Agent Resistant MDS and AML
Bianca L Rivera, S. Chakraborty, Yang Shi, Hui Zhang +15 more
2022Blood2 citations Open access
Semantic Scholar
A Co-Management Model for Myeloid Malignancies That Evolved during the COVID-19 Pandemic
Niyati Goradia, Aditi Shastri, Amit Verma, E. Feldman +12 more
2022Acta Haematologica2 citations Open access
Semantic Scholar
Pyrimethamine overcomes resistance to hypomethylating agents by reducing de-novo pyrimidine synthesis.
B. Rivera-Peña, S. Chakraborty, Yang Shi, Hui Zhang +26 more
2026Experimental Hematology1 citations Open access
Semantic Scholar
First-in-human study of CTX130, a CD70-directed allogeneic CAR T therapy, in adult T-cell leukemia/lymphoma: Clinical and genomics findings from a long-term follow-up of subgroup analysis from the cobalt-LYM Phase 1 trial
E. Cordover, Kimberly Seymour, Buse Eglenen Polat, Santiago Beltran +21 more
2025Blood1 citations
Semantic Scholar
FIRST‐IN‐HUMAN CART CELLS FOR ADULT T‐CELL LEUKEMIA/LYMPHOMA USING CTX130, A CD70‐TARGETED ALLOGENEIC CRISPR‐Cas9‐ENGINEERED CART‐CELLS. COBALT‐LYM STUDY COHORT
R. Sica, E. Cordover, J. Nguyen, K. Seymour +48 more
2025Hematological Oncology1 citations
Semantic Scholar
Efficacy and manageable toxicity of mogamulizumab in a real-world North American cohort of adult T-cell leukemia/lymphoma (ATLL).
E. Cordover, K. Pradhan, Latoya S. Townsend, M. Goldfinger +16 more
2025Journal of Clinical Oncology1 citations
Semantic Scholar
Dosing decitabine and venetoclax for terminal differentiation to improve outcomes in TP53 mutant MDS and AML.
Bradley Rockwell, Ioannis Mantzaris, Aditi Shastri, Brian A. Jonas +16 more
2025Journal of Clinical Oncology1 citations
Semantic Scholar
CNS Involvement by North American-Adult T-cell Leukemia/Lymphoma Is Associated With Discrete Dissemination Patterns and Molecular Profiles, Involving XPO1 E571 and KLF2/PI3KCD in Selected Cases
Nishi Shah, Melissa Suchanek, A. Thakkar, Riya Patel +20 more
2025JCO Precision Oncology1 citations Open access
Semantic Scholar
Use of the IgG degrader imlifidase for a poorly desensitized patient undergoing haematopoietic stem cell transplantation with donor‐specific antibodies
D. Cooper, J. Verceles, Taba Kheradmand, Monika Paroder +12 more
2025British Journal of Haematology1 citations
Semantic Scholar
Metronomic Low-Dose Regimen of Decitabine and Venetoclax Is Safe and Efficacious for Chronic Myelomonocytic Leukemia
Bradley Rockwell, Ioannis Mantzaris, Aditi Shastri, K. Gritsman +16 more
2024Blood1 citations
Semantic Scholar
A STAT3 Degrader Demonstrates Pre-clinical Efficacy in Venetoclax resistant Acute Myeloid Leukemia
S. Chakraborty, Claudia Morganti, Bianca Rivera Pena, Hui Zhang +27 more
2024bioRxiv1 citations Open access
Semantic Scholar
Venetoclax Alone or in Combination Shows Promising Activity in Preclinical Models and Clinical Cases of Relapsed/Refractory North American Adult T-Cell Leukemia Lymphoma
A. Tanwar, E. Cordover, Shikhar Sharma, Zixuan Tong +28 more
2024Blood1 citations
Semantic Scholar
Myelofibrosis prognostic models validated in an underserved minority population: A retrospective analysis.
J. Kamel, John Yan, M. Goldfinger, E. Feldman +10 more
2024Journal of Clinical Oncology1 citations
Semantic Scholar
Promising Safety and Efficacy Data for Peginterferon Alfa-2a (PEG-IFN) and Bictegravir/Emtricitabine/Tenofovir Alafenamide (Biktarvy) in a North American Adult T-Cell Leukemia Lymphoma (NA-ATLL) Cohort of Patients
Nechama Dreyfus, E. Cordover, K. Pradhan, Latoya S. Townsend +26 more
2024Blood1 citations
Semantic Scholar
Mogamulizumab Shows Significant Activity with Tolerable Toxicity in a Real-World North American Adult T-Cell Leukemia/Lymphoma (ATLL) Cohort
E. Cordover, K. Pradhan, Latoya S. Townsend, M. Goldfinger +17 more
2024Blood1 citations
Semantic Scholar
Immunophenotypic, genetic, and clinical characterization of adult T-cell leukemia/lymphoma: A single tertiary care center experience in the United States.
U. Edema, John Liu, Maxwell Y Ma, K. Krishnamurthy +15 more
2024American Journal of Clinical Pathology1 citations
Semantic Scholar
Testosterone therapy as a novel approach to the management of cytopenias in myelodysplastic neoplasms: a review of literature and case report
John Yan, Bradley Rockwell, Divij Verma, Srabani Sahu +2 more
2024Journal of Cancer Research and Clinical Oncology1 citations Open access
Semantic Scholar
A Study Evaluating Financial Toxicity Amongst Hematologic Malignancy Patients in the Bronx
L. Amaeshi, Alex Sisto, Lauren Laufer, Kateryna Fedorov +12 more
2023Blood1 citations
Semantic Scholar
Effective and Safe Molecular-Pharmacodynamic Once Weekly Dosing of Decitabine and Venetoclax Is a Highly Effective and Well-Tolerated Induction Therapy for AML: Interim Results of a Phase 2 Trial
M. Goldfinger, A. Epstein, Ioannis Mantzaris, Aditi Shastri +18 more
2023Blood1 citations Open access
Semantic Scholar
Ulcerative lymphomatoid papulosis following immune checkpoint inhibition and autologous stem cell transplant in a patient with recurrent Hodgkin lymphoma: a case report
Lindsay M. Pattison, Mina Aziz, M. Goldfinger, Bijal Amin +1 more
2023Acta oncologica1 citations Open access
Semantic Scholar
Transportation Cost Is a Significant Barrier to Quality Care for Hematologic Malignancy Patients in a Minority-Rich, Socioeconomically Disadvantaged Population
Lauren Laufer, L. Amaeshi, Alex Sisto, Kateryna Fedorov +12 more
2023Blood1 citations Open access
Semantic Scholar
Patterns of Leukocyte Recovery after CD19 Chimeric Antigen Receptor T-Cell Therapy in a Real-World Setting
E. Rabinovich, N. Kottapalli, Liam S. Conway-Pearson, K. Pradhan +35 more
2023Transplantation and Cellular Therapy1 citations Open access
Semantic Scholar
Pseudo-autologous Stem Cell Transplant for the Treatment of Secondary Central Nervous System Lymphoma
D. Cooper, Andrew Wollowitz, J. Verceles, Amanda Lombardo +3 more
2026Cureus0 citations Open access
Semantic Scholar
Financial Toxicity of Hematologic Malignancy Therapies, Including Cellular Therapy and Its Impact on Access to Care: Prospective Pilot Study
L. Amaeshi, L. Laufer, Kateryna Fedorov, Alex Sisto +17 more
2026JMIR Cancer0 citations Open access
Semantic Scholar
Graft-versus-host disease prophylaxis with abatacept plus intermediate dose cyclophosphamide for GVHD prophylaxis after peripheral blood stem transplantation: a single institution study
Pallavi Surana, M. Goldfinger, Ioannis Mantzaris, Marina Konopleva +20 more
2026Bone Marrow Transplantation0 citations
Semantic Scholar
Challenges of chimerism analysis using Next-Generation sequencing in a patient with complex chromosomal alterations.
Xing Li, E. Qama, K. Ramesh, K. Krishnamurthy +8 more
2026Human Immunology0 citations
Semantic Scholar
Safety and efficacy of eganelisib in adults with higher-risk myelodysplastic syndrome (HR-MDS) or relapsed/refractory (R/R) acute myeloid leukemia (AML).
M. Goldfinger, Anjali S. Advani, Irene Navarro Vicente, Jacqueline S. Garcia +11 more
2026Journal of Clinical Oncology0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Ioannis Mantzaris×38
Invite
Ioannis Mantzaris — researcher profile on SciRah
Aditi Shastri×38
Invite
Aditi Shastri — researcher profile on SciRah
K. Gritsman×34
Invite
K. Gritsman — researcher profile on SciRah
D. Cooper×33
Invite
D. Cooper — researcher profile on SciRah

×32

Invite

N. Kornblum — researcher profile on SciRah

Invite

R. Sica — researcher profile on SciRah

Invite

E. Feldman — researcher profile on SciRah

Invite

K. Pradhan — researcher profile on SciRah

Lauren C. Shapiro×18

Invite

Lauren C. Shapiro — researcher profile on SciRah

Marina Konopleva×18

Invite

Marina Konopleva — researcher profile on SciRah

Invite

Nishi Shah — researcher profile on SciRah

Invite

A. Verma — researcher profile on SciRah